{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:23:51Z","timestamp":1793039031608,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s40263-018-0495-7","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T05:53:18Z","timestamp":1518069198000},"page":"47-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence"],"prefix":"10.1007","volume":"32","author":[{"given":"Anna K.","family":"J\u00f6nsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Schill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-8420","authenticated-orcid":false,"given":"Staffan","family":"H\u00e4gg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"495_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","volume":"41","author":"JA Heit","year":"2016","unstructured":"Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis. 2016;41:3\u201314.","journal-title":"J Thromb Thrombolysis"},{"key":"495_CR2","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(11)61904-1","volume":"379","author":"SZ Goldhaber","year":"2012","unstructured":"Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835\u201346.","journal-title":"Lancet"},{"key":"495_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1055\/s-0036-1592333","volume":"42","author":"M Crous-Bou","year":"2016","unstructured":"Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42:808\u201320.","journal-title":"Semin Thromb Hemost"},{"key":"495_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1055\/s-2006-951293","volume":"32","author":"W Ageno","year":"2006","unstructured":"Ageno W, Squizzato A, Garcia D, Imberti D. Epidemiology and risk factors of venous thromboembolism. Semin Thromb Hemost. 2006;32:651\u20138.","journal-title":"Semin Thromb Hemost"},{"key":"495_CR5","first-page":"797","volume":"45","author":"H Maurice","year":"1956","unstructured":"Maurice H. Des complications phl\u00e9bitiques au cours des traitements par les neuroleptiques. L\u2019Encephale. 1956;45:797\u2013801.","journal-title":"L\u2019Encephale"},{"key":"495_CR6","first-page":"224","volume":"30","author":"H Grahmann","year":"1959","unstructured":"Grahmann H, Suchenwirth R. Thrombosis hazard in chlorpromazine and reserpine therapy of endogenous psychoses [in German]. Nervenarzt. 1959;30:224\u20135.","journal-title":"Nervenarzt"},{"key":"495_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0010-440X(65)80005-0","volume":"6","author":"H Haefner","year":"1965","unstructured":"Haefner H, Brehm I. Thromboembolic complications in neuroleptic treatment. Compr Psychiatry. 1965;6:25\u201334.","journal-title":"Compr Psychiatry"},{"key":"495_CR8","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1055\/s-0028-1106111","volume":"92","author":"K Meier-Ewert","year":"1967","unstructured":"Meier-Ewert K, Baumgart HH, Friedenberg P. Thromboembolism complications in neuro- and thymoleptic therapy [in German]. Dtsch Med Wochenschr. 1967;92:2174\u20138.","journal-title":"Dtsch Med Wochenschr"},{"key":"495_CR9","first-page":"174","volume":"38","author":"V Scholz","year":"1967","unstructured":"Scholz V. Concerning the thromboembolic complications from neuroleptic drugs [in German]. Nervenarzt. 1967;38:174\u20137.","journal-title":"Nervenarzt"},{"key":"495_CR10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1532-5415.1966.tb02866.x","volume":"14","author":"S Lal","year":"1966","unstructured":"Lal S, Bleiman M, Brown GN. Pulmonary embolism in psychiatric patients. J Am Geriatr Soc. 1966;14:1138\u201343.","journal-title":"J Am Geriatr Soc"},{"key":"495_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/00001648-199711000-00014","volume":"8","author":"AM Walker","year":"1997","unstructured":"Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology. 1997;8:671\u20137.","journal-title":"Epidemiology"},{"key":"495_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(00)02066-3","volume":"355","author":"S H\u00e4gg","year":"2000","unstructured":"H\u00e4gg S, Spigset O, S\u00f6derstr\u00f6m TG. Association of venous thromboembolism and clozapine. Lancet. 2000;355:1155\u20136.","journal-title":"Lancet"},{"key":"495_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(00)02784-7","volume":"356","author":"GL Zornberg","year":"2000","unstructured":"Zornberg GL, Jick H. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case\u2013control study. Lancet. 2000;356:1219\u201323.","journal-title":"Lancet"},{"key":"495_CR14","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2165\/00023210-200216110-00005","volume":"16","author":"S H\u00e4gg","year":"2002","unstructured":"H\u00e4gg S, Spigset O. Antipsychotic-induced venous thromboembolism: a review of the evidence. CNS Drugs. 2002;16:765\u201376.","journal-title":"CNS Drugs"},{"key":"495_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1517\/14740330903117271","volume":"8","author":"S H\u00e4gg","year":"2009","unstructured":"H\u00e4gg S, J\u00f6nsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8:537\u201347.","journal-title":"Expert Opin Drug Saf"},{"key":"495_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2165\/11633920-000000000-00000","volume":"26","author":"AK J\u00f6nsson","year":"2012","unstructured":"J\u00f6nsson AK, Spigset O, H\u00e4gg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012;26:649\u201362.","journal-title":"CNS Drugs"},{"key":"495_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2146\/ajhp070638","volume":"65","author":"CA Paciullo","year":"2008","unstructured":"Paciullo CA. Evaluating the association between clozapine and venous thromboembolism. Am J Health Syst Pharm. 2008;65:1825\u20139.","journal-title":"Am J Health Syst Pharm"},{"key":"495_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1440-1819.2007.01773.x","volume":"62","author":"R Mal\u00fd","year":"2008","unstructured":"Mal\u00fd R, Masopust J, Hos\u00e1k L, Konupc\u00edkov\u00e1 K. Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry Clin Neurosci. 2008;62:3\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"key":"495_CR19","first-page":"19","volume":"23","author":"V Neste","year":"2009","unstructured":"Neste V, Verbruggen W, Leysen M. Deep venous thrombosis and pulmonary embolism in psychiatric settings. Eur J Psychiatry. 2009;23:19\u201330.","journal-title":"Eur J Psychiatry"},{"issue":"Suppl 1","key":"495_CR20","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.thromres.2012.08.267","volume":"130","author":"C Tromeur","year":"2012","unstructured":"Tromeur C, Couturaud F. Antipsychotic drugs and venous thromboembolism. Thromb Res. 2012;130(Suppl 1):S29\u201331.","journal-title":"Thromb Res"},{"key":"495_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/pcn.12001","volume":"66","author":"J Masopust","year":"2012","unstructured":"Masopust J, Mal\u00fd R, Vali\u0161 M. Risk of venous thromboembolism during treatment with antipsychotic agents. Psychiatry Clin Neurosci. 2012;66:541\u201352.","journal-title":"Psychiatry Clin Neurosci"},{"key":"495_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-0031-1280814","volume":"44","author":"R Zhang","year":"2011","unstructured":"Zhang R, Dong L, Shao F, Tan X, Ying K. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44:183\u20138.","journal-title":"Pharmacopsychiatry"},{"key":"495_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40264-013-0127-6","volume":"37","author":"C Barbui","year":"2014","unstructured":"Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37:79\u201390.","journal-title":"Drug Saf"},{"issue":"78","key":"495_CR24","first-page":"1724","volume":"1953","author":"G Brehmer","year":"1946","unstructured":"Brehmer G, Ruckdeschel KT. Technic of the hibernation therapy. Dtsch Med Wochenschr. 1953(78):1724\u20135.","journal-title":"Dtsch Med Wochenschr"},{"key":"495_CR25","first-page":"338","volume":"73","author":"F Labhardt","year":"1954","unstructured":"Labhardt F. Technic, side effects and complications of largactil therapy [in German. Schweiz Arch Neurol Psychiatr. 1954;73:338\u201345.","journal-title":"Schweiz Arch Neurol Psychiatr"},{"key":"495_CR26","first-page":"121","volume":"5","author":"G Lunel","year":"1972","unstructured":"Lunel G, Noble Y, Arn\u00e9 L. The thrombogenic role of neuroleptic agents (apropos of 2 cases) [in French]. Bord Med. 1972;5:121\u20136.","journal-title":"Bord Med"},{"key":"495_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0033-3182(83)73114-2","volume":"24","author":"I Varia","year":"1983","unstructured":"Varia I, Krishnan RR, Davidson J. Deep-vein thrombosis with antipsychotic drugs. Psychosomatics. 1983;24:1097\u20138.","journal-title":"Psychosomatics"},{"key":"495_CR28","first-page":"239","volume":"2","author":"D Ruh-Bernhardt","year":"1976","unstructured":"Ruh-Bernhardt D, Finance F, Rohmer F, Singer L. Influence of psychotropic therapy on thrombogenesis and platelet functions. A propos of 4 cases of thromboembolic accidents occurring in patients treated by neuroleptics and antidepressants [in French]. L\u2019Encephale. 1976;2:239\u201355.","journal-title":"L\u2019Encephale"},{"key":"495_CR29","first-page":"256","volume":"1","author":"L Singer","year":"1975","unstructured":"Singer L, Finance MF, Ruh MD. Pulmonary embolisms occurring in 1 month in 3 aged women with manic-depressive psychoses. Discussion. Etiopathogenic role or psychiatric treatment [in French]. Ann Med Psychol (Paris). 1975;1:256\u201363.","journal-title":"Ann Med Psychol (Paris)"},{"key":"495_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00355730","volume":"204","author":"MH Mahmoodian","year":"1963","unstructured":"Mahmoodian MH. Ursachen der Lungenembolie bei psychisch und neurologisch Kranken. Arch F\u00fcr Psychiatr Nervenkrankh. 1963;204:229\u201344.","journal-title":"Arch F\u00fcr Psychiatr Nervenkrankh"},{"key":"495_CR31","first-page":"184","volume":"14","author":"K Kendel","year":"1969","unstructured":"Kendel K, Fodor S. Pulmonary embolism and symptomatic psychosis. Ger Med Mon. 1969;14:184\u20137.","journal-title":"Ger Med Mon"},{"key":"495_CR32","first-page":"1063","volume":"72","author":"H Ziegler","year":"1977","unstructured":"Ziegler H. Lungenembolie aus der Sicht des Pathologen. Med Klin. 1977;72:1063\u201370.","journal-title":"Med Klin"},{"key":"495_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1472-8206.2007.00515.x","volume":"21","author":"K Lacut","year":"2007","unstructured":"Lacut K, Le Gal G, Couturaud F, Cornily G, Leroyer C, Mottier D, et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case\u2013control study. Fundam Clin Pharmacol. 2007;21:643\u201350.","journal-title":"Fundam Clin Pharmacol"},{"key":"495_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/13651500601017357","volume":"11","author":"J Masopust","year":"2007","unstructured":"Masopust J, Mal\u00fd R, Urban A, Hos\u00e1k L, \u010cerm\u00e1kov\u00e1 E. Antipsychotic drugs as a risk factor for venous thromboembolism. Int J Psychiatry Clin Pract. 2007;11:246\u20139.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"495_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/CLEP.S4969","volume":"1","author":"AK J\u00f6nsson","year":"2009","unstructured":"J\u00f6nsson AK, Horv\u00e1th-Puh\u00f3 E, H\u00e4gg S, Pedersen L, S\u00f8rensen HT. Antipsychotics and risk of venous thromboembolism: a population-based case\u2013control study. Clin Epidemiol. 2009;1:19\u201326.","journal-title":"Clin Epidemiol"},{"key":"495_CR36","doi-asserted-by":"publisher","first-page":"c4245","DOI":"10.1136\/bmj.c4245","volume":"341","author":"C Parker","year":"2010","unstructured":"Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case\u2013control study. BMJ. 2010;341:c4245.","journal-title":"BMJ"},{"key":"495_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/pds.3699","volume":"23","author":"C Ishiguro","year":"2014","unstructured":"Ishiguro C, Wang X, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case\u2013control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014;23:1168\u201375.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"495_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.4088\/JCP.12m08117","volume":"74","author":"C-S Wu","year":"2013","unstructured":"Wu C-S, Lin C-C, Chang C-M, Wu K-Y, Liang H-Y, Huang Y-W, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013;74:918\u201324.","journal-title":"J Clin Psychiatry"},{"key":"495_CR39","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1160\/TH15-11-0895","volume":"115","author":"M-T Wang","year":"2016","unstructured":"Wang M-T, Liou J-T, Huang Y-W, Lin CW, Wu G-J, Chu C-L, et al. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women. A population-based nested case\u2013control study. Thromb Haemost. 2016;115:1209\u201319.","journal-title":"Thromb Haemost"},{"key":"495_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12888-015-0479-9","volume":"15","author":"V Conti","year":"2015","unstructured":"Conti V, Venegoni M, Cocci A, Fortino I, Lora A, Barbui C. Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case\u2013control study. BMC Psychiatry. 2015;15:92.","journal-title":"BMC Psychiatry"},{"key":"495_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11096-017-0441-7","volume":"39","author":"A Premu\u0161 Maru\u0161i\u010d","year":"2017","unstructured":"Premu\u0161 Maru\u0161i\u010d A, Petrovi\u010d D, Mrhar A, Locatelli I. Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case\u2013control study. Int J Clin Pharm. 2017;39:416\u201323.","journal-title":"Int J Clin Pharm"},{"key":"495_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/JCP.0b013e3181f0e87d","volume":"30","author":"BC Kleijer","year":"2010","unstructured":"Kleijer BC, Heerdink ER, Egberts TCG, Jansen PAF, van Marum RJ. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients. J Clin Psychopharmacol. 2010;30:526\u201330.","journal-title":"J Clin Psychopharmacol"},{"key":"495_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/JCP.0b013e3182a412d5","volume":"33","author":"N Schmedt","year":"2013","unstructured":"Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013;33:753\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"495_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pds.841","volume":"12","author":"L Parkin","year":"2003","unstructured":"Parkin L, Skegg DC, Herbison GP, Paul C. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003;12:647\u201352.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"495_CR45","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1253\/circj.68.850","volume":"68","author":"S Hamanaka","year":"2004","unstructured":"Hamanaka S, Kamijo Y, Nagai T, Kurihara K, Tanaka K, Soma K, et al. Massive pulmonary thromboembolism demonstrated at necropsy in Japanese psychiatric patients treated with neuroleptics including atypical antipsychotics. Circ J. 2004;68:850\u20132.","journal-title":"Circ J"},{"key":"495_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/pds.2210","volume":"21","author":"B Allenet","year":"2012","unstructured":"Allenet B, Schmidlin S, Genty C, Bosson J-L. Antipsychotic drugs and risk of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2012;21:42\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"495_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2015.01.012","volume":"162","author":"W-Y Hsu","year":"2015","unstructured":"Hsu W-Y, Lane H-Y, Lin C-L, Kao C-H. A population-based cohort study on deep vein thrombosis and pulmonary embolism among schizophrenia patients. Schizophr Res. 2015;162:248\u201352.","journal-title":"Schizophr Res"},{"key":"495_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/JCP.0000000000000738","volume":"37","author":"A Ferraris","year":"2017","unstructured":"Ferraris A, Szmulewicz AG, Vazquez FJ, Vollmer WM, Angriman F. Antipsychotic use among adult outpatients and venous thromboembolic disease: a retrospective cohort study. J Clin Psychopharmacol. 2017;37:405\u201311.","journal-title":"J Clin Psychopharmacol"},{"key":"495_CR49","doi-asserted-by":"publisher","first-page":"d4656","DOI":"10.1136\/bmj.d4656","volume":"343","author":"J Hippisley-Cox","year":"2011","unstructured":"Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.","journal-title":"BMJ"},{"key":"495_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jjcc.2016.10.012","volume":"70","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Yamada N, Oda E, Matsubayashi D, Ota K, Kobayashi M, et al. Predictors of venous thromboembolism recurrence and the bleeding events identified using a Japanese healthcare database. J Cardiol. 2017;70:155\u201362.","journal-title":"J Cardiol"},{"key":"495_CR51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0037-1613188","volume":"88","author":"JG Ray","year":"2002","unstructured":"Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost. 2002;88:205\u20139.","journal-title":"Thromb Haemost"},{"key":"495_CR52","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1001\/archinte.165.22.2677","volume":"165","author":"R Liperoti","year":"2005","unstructured":"Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med. 2005;165:2677\u201382.","journal-title":"Arch Intern Med"},{"key":"495_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40120-016-0060-6","volume":"6","author":"M Dennis","year":"2017","unstructured":"Dennis M, Shine L, John A, Marchant A, McGregor J, Lyons RA, et al. Risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study. Neurol Ther. 2017;6:57\u201377.","journal-title":"Neurol Ther"},{"key":"495_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/YIC.0b013e3282fe9d44","volume":"23","author":"AK J\u00f6nsson","year":"2008","unstructured":"J\u00f6nsson AK, Brudin L, Ahlner J, Hedenmalm K, Eriksson A, H\u00e4gg S. Antipsychotics associated with pulmonary embolism in a Swedish medicolegal autopsy series. Int Clin Psychopharmacol. 2008;23:263\u20138.","journal-title":"Int Clin Psychopharmacol"},{"key":"495_CR55","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2165\/00002018-200831080-00005","volume":"31","author":"S H\u00e4gg","year":"2008","unstructured":"H\u00e4gg S, Bate A, Stahl M, Spigset O. Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions. Drug Saf. 2008;31:685\u201394.","journal-title":"Drug Saf"},{"key":"495_CR56","first-page":"1","volume":"28","author":"M Letmaier","year":"2017","unstructured":"Letmaier M, Grohmann R, Kren C, Toto S, Bleich S, Engel R, et al. Venous thromboembolism during treatment with antipsychotics: results of a drug surveillance programme. World J Biol Psychiatry. 2017;28:1\u201312.","journal-title":"World J Biol Psychiatry"},{"key":"495_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1192\/bjp.179.1.63","volume":"179","author":"R Thomassen","year":"2001","unstructured":"Thomassen R, Vandenbroucke JP, Rosendaal FR. Antipsychotic medication and venous thrombosis. Br J Psychiatry J Ment Sci. 2001;179:63\u20136.","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"495_CR58","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0140-6736(05)74503-7","volume":"356","author":"J Wolstein","year":"2000","unstructured":"Wolstein J, Grohmann R, R\u00fcther E, Hippius H. Antipsychotic drugs and venous thromboembolism. Lancet. 2000;356:252.","journal-title":"Lancet"},{"key":"495_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/asheducation-2005.1.1","volume":"2005","author":"FR Rosendaal","year":"2005","unstructured":"Rosendaal FR. Venous thrombosis: the role of genes, environment, and behavior. Hematol Am Soc Hematol Educ Program. 2005;2005:1\u201312.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"495_CR60","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/archinte.167.9.935","volume":"167","author":"C Huerta","year":"2007","unstructured":"Huerta C, Johansson S, Wallander M-A, Garc\u00eda Rodr\u00edguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167:935\u201343.","journal-title":"Arch Intern Med"},{"key":"495_CR61","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1210\/jcem.86.12.8085","volume":"86","author":"H Wallaschofski","year":"2001","unstructured":"Wallaschofski H, Donn\u00e9 M, Eigenthaler M, Hentschel B, Faber R, Stepan H, et al. PRL as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab. 2001;86:5912\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"495_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.jcp.0000088914.24613.51","volume":"23","author":"H Wallaschofski","year":"2003","unstructured":"Wallaschofski H, Eigenthaler M, Kiefer M, Donn\u00e9 M, Hentschel B, Gertz HJ, et al. Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. J Clin Psychopharmacol. 2003;23:479\u201383.","journal-title":"J Clin Psychopharmacol"},{"key":"495_CR63","first-page":"518","volume":"28","author":"A Urban","year":"2007","unstructured":"Urban A, Masopust J, Mal\u00fd R, Hos\u00e1k L, Kalnick\u00e1 D. Prolactin as a factor for increased platelet aggregation. Neuro Endocrinol Lett. 2007;28:518\u201323.","journal-title":"Neuro Endocrinol Lett"},{"key":"495_CR64","first-page":"421","volume":"28","author":"J Peuskens","year":"2014","unstructured":"Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs. 2014;28:421\u201353.","journal-title":"CNS Drugs"},{"key":"495_CR65","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1681.2007.04650.x","volume":"34","author":"S Axelsson","year":"2007","unstructured":"Axelsson S, H\u00e4gg S, Eriksson AC, Lindahl TL, Whiss PA. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation. Clin Exp Pharmacol Physiol. 2007;34:775\u201380.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"495_CR66","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0149-2918(04)80097-3","volume":"26","author":"F Clerck De","year":"2004","unstructured":"De Clerck F, Somers Y, Mannaert E, Greenspan A, Eerdekens M. In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis. Clin Ther. 2004;26:1261\u201373.","journal-title":"Clin Ther"},{"key":"495_CR67","first-page":"351","volume":"24","author":"M Schwartz","year":"1999","unstructured":"Schwartz M, Rochas M, Toubi E, Sharf B. The presence of lupus anticoagulant and anticardiolipin antibodies in patients undergoing long-term neuroleptic treatment. J Psychiatry Neurosci. 1999;24:351\u20132.","journal-title":"J Psychiatry Neurosci"},{"key":"495_CR68","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/37.3.346","volume":"37","author":"MS Lillicrap","year":"1998","unstructured":"Lillicrap MS, Wright G, Jones AC. Symptomatic antiphospholipid syndrome induced by chlorpromazine. Br J Rheumatol. 1998;37:346\u20137.","journal-title":"Br J Rheumatol"},{"key":"495_CR69","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0924-9338(97)81063-2","volume":"11","author":"J Ayuso","year":"1996","unstructured":"Ayuso J, Saiz Ruiz J. Neuroleptic-induced antinuclear antibodies. Eur Psychiatry. 1996;11:378\u20139.","journal-title":"Eur Psychiatry"},{"key":"495_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0006-3223(90)90467-G","volume":"27","author":"RT Canoso","year":"1990","unstructured":"Canoso RT, de Oliveira RM, Nixon RA. Neuroleptic-associated autoantibodies. A prevalence study. Biol Psychiatry. 1990;27:863\u201370.","journal-title":"Biol Psychiatry"},{"key":"495_CR71","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ajh.2830270408","volume":"27","author":"RT Canoso","year":"1988","unstructured":"Canoso RT, de Oliveira RM. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis. Am J Hematol. 1988;27:272\u20135.","journal-title":"Am J Hematol"},{"key":"495_CR72","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/00007611-199402000-00008","volume":"87","author":"WS Metzer","year":"1994","unstructured":"Metzer WS, Canoso RT, Newton JE. Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy. South Med J. 1994;87:190\u20132.","journal-title":"South Med J"},{"key":"495_CR73","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/art.1780310716","volume":"31","author":"VD Steen","year":"1988","unstructured":"Steen VD, Ramsey-Goldman R. Phenothiazine-induced systemic lupus erythematosus with superior vena cava syndrome: case report and review of the literature. Arthritis Rheum. 1988;31:923\u20136.","journal-title":"Arthritis Rheum"},{"key":"495_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0033-3182(88)72430-5","volume":"29","author":"RS el-Mallakh","year":"1988","unstructured":"el-Mallakh RS, Donaldson JO, Kranzler HR, Racy A. Phenothiazine-associated lupus anticoagulant and thrombotic disease. Psychosomatics. 1988;29:109\u201313.","journal-title":"Psychosomatics"},{"key":"495_CR75","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ajh.2830460233","volume":"46","author":"S Davis","year":"1994","unstructured":"Davis S, Kern HB, Asokan R. Antiphospholipid antibodies associated with clozapine treatment. Am J Hematol. 1994;46:166\u20137.","journal-title":"Am J Hematol"},{"key":"495_CR76","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jpsychires.2008.09.009","volume":"43","author":"H Shen","year":"2009","unstructured":"Shen H, Li R, Xiao H, Zhou Q, Cui Q, Chen J. Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients. J Psychiatr Res. 2009;43:615\u20139.","journal-title":"J Psychiatr Res"},{"key":"495_CR77","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1378\/chest.98.6.1545a","volume":"98","author":"P Roche-Bayard","year":"1990","unstructured":"Roche-Bayard P, Rossi R, Mann JM, Cordier JF, Delahaye JP. Left pulmonary artery thrombosis in chlorpromazine-induced lupus. Chest. 1990;98:1545.","journal-title":"Chest"},{"key":"495_CR78","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psychres.2010.04.049","volume":"187","author":"S-H Chang","year":"2011","unstructured":"Chang S-H, Chiang S-Y, Chiu C-C, Tsai C-C, Tsai H-H, Huang C-Y, et al. Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia. Psychiatry Res. 2011;187:341\u20136.","journal-title":"Psychiatry Res"},{"key":"495_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.psychres.2008.05.011","volume":"169","author":"K Halacheva","year":"2009","unstructured":"Halacheva K, Dimova S, Tolev T, Dimov D, Nikolova M. Elevated anticardiolipin antibodies in schizophrenic patients before and during neuroleptic medication. Psychiatry Res. 2009;169:51\u20135.","journal-title":"Psychiatry Res"},{"key":"495_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.schres.2016.01.034","volume":"171","author":"B Stubbs","year":"2016","unstructured":"Stubbs B, Williams J, Gaughran F, Craig T. How sedentary are people with psychosis? A systematic review and meta-analysis. Schizophr Res. 2016;171:103\u20139.","journal-title":"Schizophr Res"},{"key":"495_CR81","first-page":"21","volume":"56","author":"WV McCall","year":"1995","unstructured":"McCall WV, Mann SC, Shelp FE, Caroff SN. Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review. J Clin Psychiatry. 1995;56:21\u20135.","journal-title":"J Clin Psychiatry"},{"key":"495_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jama.1972.03200040099034","volume":"220","author":"RJ Sukov","year":"1972","unstructured":"Sukov RJ. Thrombophlebitis as a complication of severe catatonia. JAMA. 1972;220:587\u20138.","journal-title":"JAMA"},{"key":"495_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2016.04.105","volume":"241","author":"T Ishida","year":"2016","unstructured":"Ishida T, Sakurai H, Watanabe K, Iwashita S, Mimura M, Uchida H. Incidence of deep vein thrombosis in catatonic patients: a chart review. Psychiatry Res. 2016;241:61\u20135.","journal-title":"Psychiatry Res"},{"key":"495_CR84","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.schres.2012.10.041","volume":"143","author":"F Dickerson","year":"2013","unstructured":"Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yang S, et al. C-reactive protein is elevated in schizophrenia. Schizophr Res. 2013;143:198\u2013202.","journal-title":"Schizophr Res"},{"issue":"680","key":"495_CR85","first-page":"e5","volume":"35","author":"M \u0160tuhec","year":"2013","unstructured":"\u0160tuhec M. Clozapine-induced elevated C-reactive protein and fever mimic infection. Gen Hosp Psychiatry. 2013;35(680):e5\u20136.","journal-title":"Gen Hosp Psychiatry"},{"key":"495_CR86","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.schres.2010.06.002","volume":"121","author":"FJ Diaz","year":"2010","unstructured":"Diaz FJ, P\u00e9rez-Iglesias R, Mata I, Mart\u00ednez-Garcia O, V\u00e1zquez-Barquero JL, de Leon J, et al. Possible effects of some antipsychotic drugs on C-reactive protein in a drug-na\u00efve psychotic sample. Schizophr Res. 2010;121:207\u201312.","journal-title":"Schizophr Res"},{"key":"495_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-244X-11-2","volume":"11","author":"J Masopust","year":"2011","unstructured":"Masopust J, Mal\u00fd R, Andr\u00fds C, Vali\u0161 M, Ba\u017eant J, Hos\u00e1k L. Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry. 2011;11:2.","journal-title":"BMC Psychiatry"},{"key":"495_CR88","doi-asserted-by":"crossref","first-page":"872","DOI":"10.5858\/2007-131-872-HATAO","volume":"131","author":"MM Eldibany","year":"2007","unstructured":"Eldibany MM, Caprini JA. Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med. 2007;131:872\u201384.","journal-title":"Arch Pathol Lab Med"},{"key":"495_CR89","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00702-003-0061-3","volume":"110","author":"A Reif","year":"2003","unstructured":"Reif A, Schneider MF, Kamolz S, Pfuhlmann B. Homocysteinemia in psychiatric disorders: association with dementia and depression, but not schizophrenia in female patients. J Neural Transm (Vienna). 2003;110:1401\u201311.","journal-title":"J Neural Transm (Vienna)"},{"key":"495_CR90","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1055\/s-2006-951456","volume":"32","author":"M Cattaneo","year":"2006","unstructured":"Cattaneo M. Hyperhomocysteinemia and venous thromboembolism. Semin Thromb Hemost. 2006;32:716\u201323.","journal-title":"Semin Thromb Hemost"},{"key":"495_CR91","unstructured":"National Institute for Health and Care Excellence. Venous thromboembolism in adults: diagnosis and management. NICE guidance and guidelines. https:\/\/www.nice.org.uk\/guidance\/qs29 . Cited 14 July 2017."},{"key":"495_CR92","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archinte.1994.00420060103011","volume":"154","author":"FA Anderson","year":"1994","unstructured":"Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Changing clinical practice. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med. 1994;154:669\u201377.","journal-title":"Arch Intern Med"},{"key":"495_CR93","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1001\/jama.283.21.2816","volume":"283","author":"P Durieux","year":"2000","unstructured":"Durieux P, Nizard R, Ravaud P, Mounier N, Lepage E. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA. 2000;283:2816\u201321.","journal-title":"JAMA"},{"key":"495_CR94","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/1817-1737.114298","volume":"8","author":"HM Al-Dorzi","year":"2013","unstructured":"Al-Dorzi HM, Cherfan A, Al-Harbi S, Al-Askar A, Al-Azzam S, Hroub A, et al. Knowledge of thromboprophylaxis guidelines pre- and post-didactic lectures during a venous thromboembolism awareness day at a tertiary-care hospital. Ann Thorac Med. 2013;8:165\u20139.","journal-title":"Ann Thorac Med"},{"key":"495_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11239-012-0780-0","volume":"35","author":"W Huang","year":"2013","unstructured":"Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ. Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis. 2013;35:67\u201380.","journal-title":"J Thromb Thrombolysis"},{"key":"495_CR96","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11239-017-1501-5","volume":"44","author":"F Ye","year":"2017","unstructured":"Ye F, Stalvey C, Khuddus MA, Winchester DE, Toklu HZ, Mazza JJ, et al. A systematic review of mobility\/immobility in thromboembolism risk assessment models for hospitalized patients. J Thromb Thrombolysis. 2017;44:94\u2013103.","journal-title":"J Thromb Thrombolysis"},{"key":"495_CR97","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1160\/TH05-06-0385","volume":"94","author":"AT Cohen","year":"2005","unstructured":"Cohen AT, Alikhan R, Arcelus JI, Bergmann J-F, Haas S, Merli GJ, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost. 2005;94:750\u20139.","journal-title":"Thromb Haemost"},{"key":"495_CR98","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1017\/S1041610212002268","volume":"25","author":"X Liu","year":"2013","unstructured":"Liu X, O\u2019Rourke F, Van Nguyen H. Venous thromboembolism in psychogeriatric in-patients\u2014a study of risk assessment, incidence, and current prophylaxis prescribing. Int Psychogeriatr. 2013;25:913\u20137.","journal-title":"Int Psychogeriatr"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-018-0495-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-018-0495-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T22:20:06Z","timestamp":1693520406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-018-0495-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["495"],"URL":"https:\/\/doi.org\/10.1007\/s40263-018-0495-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"8 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Anna K J\u00f6nsson, Johan Schill, Hans Olsson, Olav Spigset and Staffan H\u00e4gg have no conflicts of interest relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}